New Startup Pledges to Develop Drug to Fight Pituitary Tumors

A new pharmaceutical startup called Tiberio has just launched with $31 million in funding- with the stated goal of developing drugs that target pituitary tumors. The company has licensed two compounds from Ipsen Pharmaceuticals and plans to do additional research. One compound, TBR-760 previously failed in tests to combat acromegaly but Tiberio believes it shows promise for shrinking other types of pituitary tumors. Read more here:


Available Now!

PPRG6-500 Cover
The Pituitary Patient Resource Guide Sixth Edition is now available! Be one of the first to have the most up-to-date information. The Pituitary Patient Resource Guide a one of a kind publication intended as an invaluable source of information not only for patients but also their families, physicians, and all health care providers. It contains information on symptoms, proper testing, how to get a diagnosis, and the treatment options that are available. It also includes Pituitary Network Association's patient resource listings for expert medical care.

Buy Now